Table 6. HCV infections transmitted through unsafe injections, in 2000 and 2010.
| 2000 | 2010 | ||||
| Region | Previous estimatesa | Revised estimates pt = 0.5% | Revised estimates pt = 1.0% | Estimates pt = 0.5% | Estimates pt = 1.0% |
| AFR D | 54,681 | 19,090 | 38,164 | 2,037 | 4,075 |
| AFR E | 54,131 | 11,642 | 23,281 | 2,218 | 4,437 |
| AMR B | 2,282 | 604 | 1,208 | 2,098 | 4,195 |
| AMR D | 6,304 | 1,374 | 2,748 | 472 | 944 |
| EMR D | 645,486 | 165,688 | 328,071 | 40,556 | 81,074 |
| EUR B | 2,110 | 1,047 | 2,094 | 8,258 | 16,512 |
| EUR C | 35,668 | 12,191 | 24,372 | 4,811 | 9,621 |
| SEAR B | 94,873 | 20,334 | 40,642 | 2,561 | 5,122 |
| SEAR D | 498,166 | 558,634 | 1,084,690 | 40,270 | 80,531 |
| WPR B | 608,200 | 161,508 | 322,633 | 54,311 | 108,609 |
| World | 2,001,901 | 952,111 | 1,867,904 | 157,592 | 315,120 |
a
Used in Hauri et al., and Hutin et al.1,3